Bornaprine

DB13619

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 329.484
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

552 Data
Aclidinium The risk or severity of adverse effects can be increased when Bornaprine is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Bornaprine.
Mirabegron The risk or severity of urinary retention can be increased when Bornaprine is combined with Mirabegron.
Potassium chloride The risk or severity of gastrointestinal ulceration can be increased when Bornaprine is combined with Potassium chloride.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Bornaprine.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Bornaprine.
Tiotropium The risk or severity of adverse effects can be increased when Bornaprine is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Bornaprine is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Bornaprine is combined with Umeclidinium.
Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Bornaprine.
Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Bornaprine.
Metoclopramide The therapeutic efficacy of Bornaprine can be decreased when used in combination with Metoclopramide.
Glycopyrronium The risk or severity of adverse effects can be increased when Bornaprine is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Bornaprine is combined with Botulinum toxin type A.
Glucagon Bornaprine may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Bornaprine may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Bornaprine is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Bornaprine is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Bornaprine is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Bornaprine is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Bornaprine is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Bornaprine is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Bornaprine is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Bornaprine is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Bornaprine is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Bornaprine is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Bornaprine is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Bornaprine is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Bornaprine is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Bornaprine is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Bornaprine is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Bornaprine is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Bornaprine is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Bornaprine is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Bornaprine is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Bornaprine is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Bornaprine is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Bornaprine is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Bornaprine is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Bornaprine is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Bornaprine is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Bornaprine is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Bornaprine is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Bornaprine is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Bornaprine is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Bornaprine is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Bornaprine is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Bornaprine is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Bornaprine is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Bornaprine is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Bornaprine is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Bornaprine is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Bornaprine is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Bornaprine is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Bornaprine is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Bornaprine is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Bornaprine is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Bornaprine is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Bornaprine is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Bornaprine is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Bornaprine is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Bornaprine.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Bornaprine.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Bornaprine.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Bornaprine.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Bornaprine.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Bornaprine.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Bornaprine.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Bornaprine.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Bornaprine.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Bornaprine.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Bornaprine.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Bornaprine.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Bornaprine.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Bornaprine.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Bornaprine.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Bornaprine.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Bornaprine.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Bornaprine.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Bornaprine.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Bornaprine.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Bornaprine.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Bornaprine.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Bornaprine.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Bornaprine.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Bornaprine.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Bornaprine.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Bornaprine.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Bornaprine.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Bornaprine.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Bornaprine.

Referensi & Sumber

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul